Olufenwa Milhouse, MD
Urology · Chicago, ILNPI 1225353717
Payments from drug & device makers
Across 140 payments — averaging $94.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Axonics, Inc.$3K
- Valencia Technologies Corporation$3K
- Intuitive Surgical$2K
- Boston Scientific$683
- Astellas Pharma US Inc$276
- plus $2K from 19 others
What the payments were for
- Consulting fees$1,36010%
- Speaking & faculty fees$1,56012%
- Travel & lodging$4,09831%
- Food & beverage$4,49934%
- Education$1,72513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 18 | $3,467 |
| Axonics, Inc. | 35 | $2,704 |
| Valencia Technologies Corporation | 4 | $2,525 |
| Intuitive Surgical | 2 | $1,526 |
| Boston Scientific | 16 | $683 |
| Astellas Pharma US Inc | 7 | $276 |
| Coloplast | 4 | $271 |
| Teleflex LLC | 6 | $260 |
| 180 Medical, Inc. | 6 | $258 |
| Urovant Sciences Inc | 9 | $245 |
| Cosette Pharmaceuticals Inc. | 2 | $193 |
| Neotract Inc. | 1 | $121 |
| Convatec Inc. | 3 | $111 |
| KARL Storz Lithotripsy-america | 1 | $104 |
| AbbVie(2 entities) | 5 | $104 |
| Pfizer | 6 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $65 |
| Halozyme Inc | 3 | $55 |
| Laborie Medical Technologies Corp. | 1 | $49 |
| Antares Pharma, Inc. | 2 | $30 |
| Tolmar, Inc. | 1 | $29 |
| Endo USA, Inc. | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $22 |
| BD | 1 | $20 |
| Dentsply IH AB | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- eCoin Device Kit$2,492
- Bulkamid$1,844
- INTERSTIM$1,795
- Axonics$1,725
- DAVINCI XI$1,500
- UroLift$273
- VYLEESI$177
- GEMTESA$150
- GENERAL ERECTILE DYSFUNCTION$142
- GENERAL MALE SUI$125
- Axonics r-SNM System$124
- Modulith SLX-F2 Transportable$104
How this compares
$13,242 in reported general payments places this provider in the 80th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $3,781 |
| Tamsulosin Hcl | 16 | $192 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $122 |
Paid to pharmacies, not to this prescriber.
Other urology in Chicago
- Ashley RossChicago$2.3M
- Joshua MeeksChicago$2M
- Courtney HollowellChicago$1.9M
- Gary SteinbergChicago$1.4M
- Brian HelfandChicago$1.2M
- Simone CrivellaroChicago$1.1M
- Michael AbernChicago$1M
- Roohollah SharifiChicago$828K
- Amy KrambeckChicago$700K
- Srinivas VourgantiChicago$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.